Novavax stock (NVAX) skyrocketed Friday, up 120% on the news that French drug and vaccine giant Sanofi (SNY) is investing ...

Novavax stock (NVAX) skyrocketed on Friday, gaining as much as 120% on the news French drug and vaccine giant Sanofi (SNY) ...

Following a meeting of an advisory panel this week, the World Health Organization (WHO) recommended drugmakers to update their COVID-19 vaccine formulations to reflect the currently dominant SARS ...

For some, controversy over potential consequences of getting the COVID-19 vaccine or COVID itself is a spirited discussion. For others, like Morgan Ritz, who lives in Canton but spent most of her ...

A Nobel-prize winning chemist has accused scientists of stoking mistrust among the public by doing a “poor job” of explaining the benefits of Covid vaccines. Professor Sir David MacMillan said ...

The bespoke jabs, created using the same technology behind the Covid ... At that price the NHS will struggle to afford them. 'The drug companies will need to find a way to make the vaccines ...

What are mRNA vaccines? While the science dates back to 2005, the first vaccines to use the mRNA technology were those made by BioNTech and Moderna against the Covid virus. Messenger RNA ...

So much so that Moderna CEO Stéphane Bancel says his staff should be making the most of the investment in AI and using it a lot. More than "a lot." Bancel's suggestion: More than 20 times a day.

LONDON, April 23 (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a ...

Commenting at the time, Moderna said it believed that Pfizer and BioNTech’s Covid vaccine infringed patents Moderna filed between 2010 and 2016 covering its mRNA technology. Moderna claim ...